Skip to content

Impact of Non-medicalized ECG Practices Initiated by SAMU in Dispatch Strategies

Participants Are Not Assigned to Interventions Based on a Protocol

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07144059
Acronym
ECG-PHNM
Enrollment
350
Registered
2025-08-27
Start date
2026-02-01
Completion date
2026-12-31
Last updated
2025-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndromes

Keywords

Acute coronary syndrome, infarct, STEMI, Electrocardiogram (ECG), Coronary angiography, SAMU, SMUR, Non-medical vectors

Brief summary

The performance of an ECG by non-medicalized prehospital teams (firefighters, first responders, paramedic ambulances) is developing across the territory to cope with the increasing demand (SAMU calls) for a service that cannot meet it (limited Mobile Emergency and Resuscitation Unit - SMUR - teams). Early diagnosis of acute coronary syndrome is key to appropriate management. A delay in care can quickly lead to complications ranging from rhythm disorders to cardiac arrest. Furthermore, as with reperfusion in strokes, the earlier reperfusion treatment is initiated, the greater the beneficial effect in ST-segment elevation myocardial infarction (STEMI). Moreover, the main elements for diagnosing STEMI in the prehospital setting remain the ECG, along with the anamnesis (medical history) and clinical examination (typical pain). This is an observational, retrospective and single-center study (SAMU 91) carried out between September 1, 2023 and December 31, 2024. The inclusion criteria for our study were adult patients who had been regulated by SAMU 91 during a primary intervention and who had ST+ ACS registered in the eMUST registry. The main objective was to study the difference in the admission times of patients admitted to the emergency intensive care unit of cardiology or coronary angiography and presenting with ST+ ACS on the ECG performed by a primary SMUR team versus a non-medical team referred by the SAMU. The secondary objectives were to study the descriptive variables between the two groups (SMUR and non-medicalized vector), the typicity of pain, the mortality rate and the morbidity rate between the two groups.

Detailed description

The list of patients with ST+ ACS in department 91 during the year 2023 and 2024 were extracted from the E-Must registry (Registry for the Evaluation in Emergency Medicine of Therapeutic Strategies for Myocardial Infarction of less than 24 hours treated by the SAMU/SMUR of Île-de-France) and the missing information was retrieved via the SAMUScript medical regulation software (call schedules, address of the place of intervention,...)

Interventions

OTHERECG by the SMUR after medical interrogation by the SAMU

Patients who had the qualifying ECG by the SMUR after medical interrogation by the SAMU

OTHERECG performed by a non-medical vector

Patients who have called the emergency services with either an ECG performed by a non-medical vector (SP or ambulance), or a decision to reinforce SMUR during the first aid assessment

Sponsors

Centre Hospitalier Sud Francilien
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patient * Patient regulated by the SAMU 91 between 09/2023 and 12/2024 * Patient referred for coronary angiography for ST+ ACS * Patient registered in the E-Must register (Registry for the Evaluation in Emergency Medicine of Therapeutic Strategies for Myocardial Infarction of less than 24 hours treated by the SAMU/SMUR of Île-de-France)

Exclusion criteria

* Secondary transport

Design outcomes

Primary

MeasureTime frameDescription
Time to Coronary Angiography or Cardiology Intensive Care Admissionday 0Time between the time of the call for help and the arrival in the coronary angiography department or cardiology intensive care unit

Contacts

Primary ContactLaurenne PARIS, MD
laurenne.paris@chsf.fr01 69 13 95 79
Backup ContactCaroline TOURTE
caroline.tourte@chsf.fr01 61 69 31 50

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026